Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1994 Aug;220(2):176–182. doi: 10.1097/00000658-199408000-00009

A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer.

C S Robertson 1, S C Chung 1, S D Woods 1, S M Griffin 1, S A Raimes 1, J T Lau 1, A K Li 1
PMCID: PMC1234357  PMID: 8053740

Abstract

OBJECTIVE: The authors determined if more radical surgery with extended lymphadenectomy improves the results of gastrectomy in patients with adenocarcinoma of the gastric antrum. SUMMARY BACKGROUND DATA: The overall survival in patients with gastric cancer is disappointing. Improved survival has been reported by Japanese authors. Whether this is because of a higher number of early gastric cancers in the Japanese series, different biologic behavior in Asians, or the adoption of radical surgery with lymphadenectomy remains unclear. METHODS: R1 subtotal gastrectomy with omentectomy and R3 total gastrectomy (omentectomy, splenectomy, distal pancreatectomy, lymphatic clearance of the celiac axis, and skeletonization of vessels in the porta hepatis) were evaluated in a prospective, randomized comparison. RESULTS: Fifty-five patients were randomized--25 to the R1 group and 30 to the R3 group. The two groups were comparable for age, sex, tumor size, TNM stage, and length of follow-up. The R3 group had a longer operating time (140 vs. 260 min; p < 0.05), a greater transfusion requirement (0 vs. 2 units, p < 0.05) and a longer hospital stay (8 vs. 16 days; p < 0.05) (medians; Mann-Whitney U test). The only postoperative death was in the R3 group and was caused by intra-abdominal sepsis. Fourteen patients in the R3 group developed left subphrenic abscesses. There were no major complications in the R1 group. Overall survival was significantly better in the R1 group (median survival estimated by Kaplan-Meier method, 1511 vs. 922 days, p < 0.05, log-rank test). CONCLUSIONS: R3 total gastrectomy can be performed with a low mortality, but it has a high morbidity because of intra-abdominal sepsis. The data do not support the routine use of R3 total gastrectomy for treatment of patients with antral cancer.

Full text

PDF
178

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allum W. H., Powell D. J., McConkey C. C., Fielding J. W. Gastric cancer: a 25-year review. Br J Surg. 1989 Jun;76(6):535–540. doi: 10.1002/bjs.1800760604. [DOI] [PubMed] [Google Scholar]
  2. Dent D. M., Madden M. V., Price S. K. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988 Feb;75(2):110–112. doi: 10.1002/bjs.1800750206. [DOI] [PubMed] [Google Scholar]
  3. Diggory R. T., Cuschieri A. R2/3 gastrectomy for gastric carcinoma: an audited experience of a consecutive series. Br J Surg. 1985 Feb;72(2):146–148. doi: 10.1002/bjs.1800720226. [DOI] [PubMed] [Google Scholar]
  4. Dorsey J. S., Esses S., Goldberg M., Stone R. Esophagogastrectomy using the auto suture EEA surgical stapling instrument. Ann Thorac Surg. 1980 Oct;30(4):308–312. doi: 10.1016/s0003-4975(10)61266-0. [DOI] [PubMed] [Google Scholar]
  5. Francis D. M. Relationship between blood transfusion and tumour behaviour. Br J Surg. 1991 Dec;78(12):1420–1428. doi: 10.1002/bjs.1800781205. [DOI] [PubMed] [Google Scholar]
  6. Gennari L., Bozzetti F., Bonfanti G., Morabito A., Bufalino R., Doci R., Andreola S. Subtotal versus total gastrectomy for cancer of the lower two-thirds of the stomach: a new approach to an old problem. Br J Surg. 1986 Jul;73(7):534–538. doi: 10.1002/bjs.1800730706. [DOI] [PubMed] [Google Scholar]
  7. Gouzi J. L., Huguier M., Fagniez P. L., Launois B., Flamant Y., Lacaine F., Paquet J. C., Hay J. M. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg. 1989 Feb;209(2):162–166. doi: 10.1097/00000658-198902000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gunderson L. L. Radiation therapy: results and future possibilities. Clin Gastroenterol. 1976 Sep;5(3):743–776. [PubMed] [Google Scholar]
  9. Kampschöer G. H., Maruyama K., Sasako M., Kinoshita T., van de Velde C. J. The effects of blood transfusion on the prognosis of patients with gastric cancer. World J Surg. 1989 Sep-Oct;13(5):637–643. doi: 10.1007/BF01658891. [DOI] [PubMed] [Google Scholar]
  10. Koga S., Kaibara N., Kimura O., Nishidoi H., Kishimoto H. Prognostic significance of combined splenectomy or pancreaticosplenectomy in total and proximal gastrectomy for gastric cancer. Am J Surg. 1981 Nov;142(5):546–550. doi: 10.1016/0002-9610(81)90422-0. [DOI] [PubMed] [Google Scholar]
  11. Korenaga D., Watanabe A., Baba H., Saito A., Maehara Y., Sugimachi K. Hyperamylasemia associated with lymphadenectomy in patients surgically treated for gastric cancer. Eur J Surg Oncol. 1992 Apr;18(2):135–141. [PubMed] [Google Scholar]
  12. Lundell L., Grip I., Olbe L. Pancreatic resection additional to gastrectomy for gastric cancer. Effect on postoperative morbidity. Acta Chir Scand. 1986 Feb;152:145–149. [PubMed] [Google Scholar]
  13. Okajima K. Surgical treatment of gastric cancer with special reference to lymph node removal. Acta Med Okayama. 1977 Dec;31(6):369–382. [PubMed] [Google Scholar]
  14. Shiu M. H., Papacristou D. N., Kosloff C., Eliopoulos G. Selection of operative procedure for adenocarcinoma of the midstomach. Twenty years' experience with implications for future treatment strategy. Ann Surg. 1980 Dec;192(6):730–737. doi: 10.1097/00000658-198012000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Steele R. J., Chung S. C., Li A. K., Crofts T. J. Hepatic metastases in Hong Kong Chinese: evidence for an East-West difference in gastric cancer. Ann R Coll Surg Engl. 1987 Mar;69(2):61–63. [PMC free article] [PubMed] [Google Scholar]
  16. Sue-Ling H. M., Martin I., Griffith J., Ward D. C., Quirke P., Dixon M. F., Axon A. T., McMahon M. J., Johnston D. Early gastric cancer: 46 cases treated in one surgical department. Gut. 1992 Oct;33(10):1318–1322. doi: 10.1136/gut.33.10.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sugezawa A., Kaibara N., Sumi K., Ohta M., Kimura O., Nishidoi H., Koga S. Blood transfusion and the prognosis of patients with gastric cancer. J Surg Oncol. 1989 Oct;42(2):113–116. doi: 10.1002/jso.2930420209. [DOI] [PubMed] [Google Scholar]
  18. Suzuki H., Endo M., Nakayama K. A review of the five-year survival rate and clinicopathologic factors in stomach cancer treated by surgery alone. Int Adv Surg Oncol. 1983;6:271–308. [PubMed] [Google Scholar]
  19. Viste A., Eide G. E., Søreide O. Stomach cancer: a prospective study of anastomotic failure following total gastrectomy. Acta Chir Scand. 1987 Apr;153(4):303–306. [PubMed] [Google Scholar]
  20. Yamaguchi K., Tokui N., Maeda S., Kominami T., Nakamura K., Kitamura K. Perioperative blood transfusion and gastric cancer: adverse effects or unfavourable conditions of pretreatment? Aust N Z J Surg. 1990 Oct;60(10):765–772. doi: 10.1111/j.1445-2197.1990.tb07471.x. [DOI] [PubMed] [Google Scholar]
  21. de Aretxabala X., Konishi K., Yonemura Y., Ueno K., Yagi M., Noguchi M., Miwa K., Miyazaki I. Node dissection in gastric cancer. Br J Surg. 1987 Sep;74(9):770–773. doi: 10.1002/bjs.1800740904. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES